|Free Dividend Report|
|Stock Splits Calendar|
|AEZS Stock Split History|
|Preferred Stock Newsletter|
|AEZS Options Chain|
|AEZS Message Board|
AEterna Zentaris (AEZS) has 2 splits in our AEZS split history database. The first split for AEZS took place on October 05, 2012. This was a 1 for 6 reverse split, meaning for each 6 shares of AEZS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split. AEZS's second split took place on November 20, 2015. This was a 1 for 100 reverse split, meaning for each 100 shares of AEZS owned pre-split, the shareholder now owned 1 share. For example, a 166.666666666667 share position pre-split, became a 1.66666666666667 share position following the split.
When a company such as AEterna Zentaris conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the AEZS split history from start to finish, an original position size of 1000 shares would have turned into 1.66666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AEterna Zentaris shares, starting with a $10,000 purchase of AEZS, presented on a split-history-adjusted basis factoring in the complete AEZS split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-46.46%|
|About AEterna Zentaris|
|AEterna Zentaris is a biopharmaceutical company engaged in developing and commercializing pharmaceutical therapies, focused on the development and commercialization of Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the ghrelin receptor (GHSR-1a) and that has potential uses in both endocrinology and oncology indications. According to our AEZS split history records, AEterna Zentaris has had 2 splits.|
|AEZS Split History Table|
|10/05/2012||1 for 6|
|11/20/2015||1 for 100|
|Healthcare Stock Splits|
|AEZS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
Also explore: AEZS shares outstanding history